My dad died in September 2021 at the age of 78 of an undiagnosed #myeloma. That was abrupt, he died 3 weeks after arriving at the hospital, I still often think about that terrible month.
Beside having been a school #teacher, he painted is whole life since the age of 15, and left a large #legacy of #paintings and #drawings. I immediately thought about #digitizing his complete work, even if it looked like a huge undertaking, probably for both said and unsaid reasons.
#myeloma #teacher #legacy #paintings #drawings #Digitizing
Computational Scientist
Icahn School of Medicine at Mount Sinai
Come join our team as a #computationalScientist: #multiOmics modeling of #myeloma, including #singleCell, #spatialTranscriptomics and #flowCytometry
See the full job description on jobRxiv: https://jobrxiv.org/job/icahn-school-of-medicine-at-mount-sinai-27778-computational-scientist-5/?feed_id=47998
#ScienceJobs #hi...
https://jobrxiv.org/job/icahn-school-of-medicine-at-mount-sinai-27778-computational-scientist-5/?feed_id=47998
#hi #ScienceJobs #flowcytometry #spatialtranscriptomics #singlecell #myeloma #multiomics #computationalscientist
Postdoctoral Researcher
Icahn School of Medicine at Mount Sinai
Come join our team as a #bioinformatics postdoc: #multiOmics modeling of #myeloma, including #singleCell, #spatialTranscriptomics and #flowCytometry
See the full job description on jobRxiv: https://jobrxiv.org/job/icahn-school-of-medicine-at-mount-sinai-27778-postdoctoral-researcher-4/?feed_id=47893
#ScienceJobs #hi...
https://jobrxiv.org/job/icahn-school-of-medicine-at-mount-sinai-27778-postdoctoral-researcher-4/?feed_id=47893
#hi #ScienceJobs #flowcytometry #spatialtranscriptomics #singlecell #myeloma #multiomics #bioinformatics
Referenced link: https://phys.org/news/2023-06-nanoparticles-small-interfering-rna-multiple.html
Discuss on https://discu.eu/q/https://phys.org/news/2023-06-nanoparticles-small-interfering-rna-multiple.html
Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/physorg_com/status/1669970641221500929#m
#Nanoparticles deliver small interfering RNA to slow multiple #myeloma @PNASNews https://pnas.org/doi/10.1073/pnas.2215711120 https://phys.org/news/2023-06-nanoparticles-small-interfering-rna-multiple.html
Referenced link: https://medicalxpress.com/news/2023-06-multiple-myeloma-evolution.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-06-multiple-myeloma-evolution.html
Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1668276487076605952#m
RT by @physorg_com: Study brings new understanding of multiple #myeloma evolution https://linkinghub.elsevier.com/retrieve/pii/S1535610823001745 https://medicalxpress.com/news/2023-06-multiple-myeloma-evolution.html
Groundbreaking Israeli #cancer #treatment has a 90% success rate. An experimental treatment developed at #Israel's Hadassah-University Medical Center has a 90% success rate at bringing patients with multiple #myeloma into #remission.
https://www.jpost.com/health-and-wellness/article-744499
#cancer #treatment #israel #myeloma #remission
Computational Scientist
Icahn School of Medicine at Mount Sinai
Come join our team as a #computationalScientist: #multiOmics modeling of #myeloma, including #singleCell, #spatialTranscriptomics and #flowCytometry
See the full job description on jobRxiv: https://jobrxiv.org/job/icahn-school-of-medicine-at-mount-sinai-27778-computational-scientist-5/?feed_id=45913
#ScienceJobs #hi...
https://jobrxiv.org/job/icahn-school-of-medicine-at-mount-sinai-27778-computational-scientist-5/?feed_id=45913
#hi #ScienceJobs #flowcytometry #spatialtranscriptomics #singlecell #myeloma #multiomics #computationalscientist
Access to innovative myeloma drugs remains ‘difficult’ in France https://www.euractiv.com/section/health-consumers/news/access-to-innovative-myeloma-drugs-remains-difficult-in-france/?utm_source=dlvr.it&utm_medium=mastodon #diagnosisandtreatment #multiplemyeloma #myeloma
#diagnosisandtreatment #multiplemyeloma #myeloma
Access to innovative myeloma drugs remains ‘difficult’ in France https://www.euractiv.com/section/health-consumers/news/access-to-innovative-myeloma-drugs-remains-difficult-in-france/?utm_source=dlvr.it&utm_medium=mastodon #diagnosisandtreatment #multiplemyeloma #myeloma
#diagnosisandtreatment #MultipleMyeloma #myeloma
Multiple myeloma therapies in Poland are becoming increasingly effective https://www.euractiv.com/section/health-consumers/news/multiple-myeloma-therapies-in-poland-are-becoming-increasingly-effective/?utm_source=dlvr.it&utm_medium=mastodon #myeloma
Multiple myeloma therapies in Poland are becoming increasingly effective https://www.euractiv.com/section/health-consumers/news/multiple-myeloma-therapies-in-poland-are-becoming-increasingly-effective/?utm_source=dlvr.it&utm_medium=mastodon #myeloma
One of the good things about working at the hospital is that you can run into the cancer support nurses in the corridor and have a quick catch up on how your treatment is going. Very convenient!
Gidday, myeloma. So, you’re back. We had hoped you’d stay away for more than 18 months, but I’ve got some drugs to take care of you (hopefully). Took the first of them last night. Let’s see how long you last. And that radiation is going to sort you out in my back and leg, so don’t get too comfortable.
Light chain nephropathy: how to treat? #OpenAccess review from the Mayo
#openaccess #free #nephpearls #myeloma #AKI
I feel like I should be able to send cookies or something. "Hey. Thanks for taking one for the team. If you don't end up dead, drinks are on me."
#myeloma #CancerResearch
Probably not a lot new since the one they just did in Asia, but it's virtual and the multiple myeloma presentation is at 9:00 am (Eastern) if you feel like listening to experts talk about what lurks in your body. #multiplemyeloma #myeloma
---
RT @hemoncbp
GW 2023 Hematology Update Symposium is Sat, Feb, 25, 8AM EST. Join us Live In-Person or via Virtual Livestream https://bit.ly/hemaupdate2023
Register Today!
Sat, Feb 25, 8:00 AM EST
Mar…
https://twitter.com/hemoncbp/status/1625623520347582464
RT @End_myeloma
Now that horse is out of the barn... a few important points about KARMMA-3 #mmsm @paurotero @NBahlis @MyelomaTeacher #myeloma
1/X - First randomized phase 3 trial to show clinical benefit for Car-T cell therapy in MM. That is HUGE. https://twitter.com/RahulBanerjeeMD/status/1611391189835730947